课题基金 / 基金详情

Role of Wnt/b-catenin signaling in pulmonary fibrosis

Role of Wnt/b-catenin signaling in pulmonary fibrosis
Wnt/b-连环蛋白信号在肺纤维化中的作用
批准号:
8526492
负责人:
AI P LAM
金额:
$12.81万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-02 至 2015-02-28

项目摘要

项目成果

AI P LAM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal describes a career development plan to become a successful independent investigator and to elucidate novel molecular mechanisms in the development of pulmonary fibrosis. For this proposal, the principal investigator has brought together the expertise and experience from two leading scientists, Dr. John Varga and Dr. Cara Gottardi, in the respective fields of fibrosis and Wnt signaling to create a unique environment for exceptional mentorship in studying pulmonary fibrosis. Additional scientific and career advice will be provided by an advisory committee comprised of highly-regarded physician-scientists from the Division of Pulmonary and Critical Care Medicine at Northwestern University. Through a variety of didactic and research training modalities, this proposal will develop expertise in cell and molecular biology of the lung, especially with regard to pulmonary fibrosis. The research will be the first to demonstrate a direct causal role of beta-catenin signaling in pulmonary fibrosis and will dissect the effects of canonical Wnt/beta- catenin signaling in lung fibroblasts. In this proposal, human lung fibroblast cells will be used for in vitro studies, while transgenic gain- and loss-of-function murine bleomycin models will be used to recapitulate human pulmonary fibrosis in vivo. The aims of this proposal are: 1) To determine whether increased beta- catenin activity resulting from loss of the negative regulator, Axin2, worsens fibrosis in a bleomycin-induced pulmonary fibrosis model, 2) To determine whether decreased beta-catenin activity resulting from loss of the Wnt co-receptor, Lrp5, attenuates the bleomycin-induced fibrosis phenotype, 3) To determine whether canonical Wnt signaling is required and sufficient to increase cell proliferation via cyclin D, migration via MMP7, and transdifferentiation in human lung fibroblasts. The findings of this proposal will demonstrate the first direct causal link between the canonical Wnt/beta-catenin pathway and lung fibrosis and provide novel insights into the molecular mechanism of pulmonary fibrosis. RELEVANCE (See instructions): Fibrosis of the lung is a devastating disease for which there is currently no effective treatment or cure. We hypothesize that canonical Wnt signaling is a causal mediator of fibrosis and promotes fibrosis through the direct activation of genes that affect fibroblast proliferation/activation. The findings from this proposal will provide novel insights into the molecular mechanism for this disease and translate into the development of desperately needed therapeutics for pulmonary fibrosis. (End of Abstract)
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
The role of MRSA in healthcare-associated pneumonia.
MRSA 在医疗保健相关肺炎中的作用。
DOI: 10.1055/s-0028-1119809
发表时间: 2009
期刊: Seminars in respiratory and critical care medicine
影响因子: 3.2
作者: [Lam,AnnaP, Wunderink,RichardG]
通讯作者: Wunderink,RichardG
DOI: 10.1100/tsw.2007.16
发表时间: 2007-01-26
期刊: TheScientificWorldJournal
影响因子: --
作者: [Lam AP, Corbridge TC]
通讯作者: Corbridge TC
DOI: 10.1164/rccm.201011-1772ed
发表时间: 2011-03
期刊: American journal of respiratory and critical care medicine
影响因子: 24.7
作者: [A. Lam;C. Gottardi;R. Tuder]
通讯作者: A. Lam;C. Gottardi;R. Tuder
Methicillin-Resistant S. aureus Ventilator-Associated Pneumonia: Strategies to Prevent and Treat.
耐甲氧西林金黄色葡萄球菌呼吸机相关肺炎:预防和治疗策略。
DOI: 10.1055/s-2006-933677
发表时间: 2006
期刊: Seminars in respiratory and critical care medicine
影响因子: 3.2
作者: [Lam,AnnaP, Wunderink,RichardG]
通讯作者: Wunderink,RichardG
Wnt/beta-catenin signaling and innate immunity in pulmonary fibrosis
Role of Wnt/b-catenin signaling in pulmonary fibrosis
Role of Wnt/b-catenin signaling in pulmonary fibrosis
Role of Wnt/b-catenin signaling in pulmonary fibrosis
海外基金